About

About STEMCELL Technologies About Stemcell Technologies Inc. STEMCELL Technologies supports cancer research with a comprehensive portfolio of more than 2,500 specialized tools and services. From high-quality cell culture media and simplified cell separation technologies to high-performance instruments, including the STEMprep™ Tissue Dissociator for generating high-viability single-cell suspensions and the CellPore™ Transfection System for gentle intracellular delivery, our solutions help researchers achieve reliable, reproducible results. Complemented by essential accessories and expert scientific services, our products support every step of the cancer research workflow. STEMCELL Technologies is a trusted partner to scientists worldwide advancing discoveries in cancer biology, stem cell research, immuno-oncology, regenerative medicine, and cellular therapy. STEMCELL Technologies develops specialty cell culture media, iPSCs and iPSC-derived cells, cell isolation products, and accessory reagents for life science research. Whether you are modeling retinal diseases, advancing drug discovery, or studying human retinal development, the STEMdiff™ retinal cell culture system supports every step of your iPSC-retinal workflow. Build robust, functional human retinal pigment epithelial (RPE) models using the STEMdiff™-ACF RPE Differentiation Kit and STEMdiff™-XF RPE Maturation Medium, which are designed to support reproducibility, scalability, and physiological relevance in vitro. Backed by rigorous quality control and over 30 years of in vitro modeling expertise, STEMCELL’s tools help you move confidently from basic research to translational applications. Visit stemcell.com to learn more. With more than 30 years of in vitro modeling expertise, STEMCELL Technologies supports respiratory researchers with specialized cell culture media and accessory reagents to build physiologically relevant and reproducible pulmonary models at the air-liquid interface (ALI) or as organoids. Model all regions of the human lung using our comprehensive PneumaCult™ portfolio, which enables the expansion and differentiation of primary airway and alveolar epithelial cells. You can generate well-differentiated, pseudostratified epithelia at the ALI or as apical-in and apical-out airway organoids to study airway biology and respiratory diseases, and advance drug development. To model lung development or complex lung disorders, STEMdiff™ cell culture media comes with standardized differentiation protocols to generate lung progenitors and branching lung organoids from human pluripotent stem cells. By combining reliable innovative culture solutions, and expert scientific support, STEMCELL helps you build more predictive models to meet your evolving research or workflow requirements. Learn more at www.stemcell.com.